Major shareholder announcement – BlackRock, Inc.
March 11 2024 - 5:30AM
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 253
Major shareholder announcement
Major shareholder announcement – BlackRock,
Inc.
Pursuant to Section 30 of the Capital Markets Act,
it is hereby announced that BlackRock, Inc. has informed ChemoMetec
A/S that BlackRock, Inc. on 7 March 2024, increased its holding of
shares and voting rights in ChemoMetec A/S to 12.17% of the total
share capital and voting rights, and that the holding thus exceeds
the 10 per cent limit in section 38 of the Capital Markets Act.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chemometec AS (TG:CHY)
Historical Stock Chart
From Jul 2023 to Jul 2024